VMR’S Recorded Sessions

Thursday, October 17, 2024

Personalized therapy for stage III NSCLC – Dr. Suresh S. Ramalingam, MD, FACP, FASCO

Thursday, April 18, 2024

Adjuvant Therapy for Renal Cell Cancer – Dr. Tim Eisen PhD FRCP FMedSci

Thursday, March 14, 2024

NSCLC EGFM+ Progressing on Osimertinib, A Race for Effective Therapy, Barbara Melosky, MD, FRCP(C)

2023 RECORDED SESSIONS

Thursday, November 30, 2023

PARPi Combinations in Metastatic Prostate Cancer – Neeraj Agarwal, MD, FASCO

Thursday, Sept 21, 2023

Rethinking Radiation Therapy in the Immuno-Oncology Era – Dr. Joseph (Joe) Sia, MBChB FRANZCR PhD

Monday, June 19, 2023

 Project Optimus: Its Evolution and Its Potential Impact – Lillian Siu, MD, FRCPC, FASCO

Monday, May 29, 2023

Accessing targeted treatments in a complex healthcare system. There is hope! – Paul Wheatley-Price BSc, MBChB, FRCP (UK), MD

Monday, April 24, 2023

New strategies for accurately genotyping metastatic prostate cancer – Alex Wyatt, DPhil

Monday, February 27, 2023

The Future of Nuclear Oncology for PSMA Theranostics – Dr. James Buteau

Monday, January 30, 2023

Comprehensive Genomic Profiling (CGP): Value for Canadian Labs, Health Care Providers, and Cancer Patients – Dr. Faisal M. Khan

Monday, December 5, 2022

Let’s Get Real: Leveraging Data for Real-World Evidence to Maximize Impact.
Dr. Winson Y. Cheung

Monday, October 24, 2022

You can’t cure cancer… stop trying… give up…
Dr. Craig Gedye

Thursday, September 26, 2022

Current Management of Muscle-invasive and Advanced Urothelial Carcinoma – Nimira Alimohamed, MD, FRCPC

Thursday, August 18, 2022

Integrating Liquid Biopsies (ctDNA) Into Clinical Practice – Dr. Pashtoon M. Kasi, MD, MS

Thursday, July 21, 2022

Precision Medicine: Affording the Successes of Science – Prof. David Thomas